April is Alcohol Awareness Month
NEW HAVEN, Conn. (WTNH) — April is Alcohol Awareness Month, a time to spread awareness about the risks of alcohol abuse and promote education on responsible drinking.
Dr. Craig Allen, medical director and vice president of addiction services at Rushford, joined Good Morning Connecticut at 9 a.m. to tell us more.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Sullivan doctor gives health tips for men during Men's Health Month
SULLIVAN, Ind. (WTWO/WAWV) — June is Men's Health Month, and a local doctor is sharing some advice on staying healthy. Kilby Osborn is a physician for Sullivan County Community Hospital, and he said some health issues men should for are diseases like testicular or colon cancer. He added that if something feels off, it probably is and men should get it checked out. He suggests everyone should get physicals regularly. 'Men, women, kids, you should all be getting physicals once a year. That's a good rule of thumb. You go in, you get checked out at the doctor once a year. You have labs done once a year. We can check your vital organs. We can check your liver. We can check your kidneys. We can check your blood sugar. We can sometimes find things that you might not even notice,' said Osborn. He also emphasized the importance of catching health issues early so they're easier to treat. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
31 minutes ago
- Yahoo
The European Commission Approves Alnylam's AMVUTTRA
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 13 Biotech Stocks with Huge Upside Potential. It declared on June 9, 2025, that AMVUTTRA® (vutrisiran) has been approved by the European Commission to treat wild-type or hereditary ATTR amyloidosis with cardiomyopathy (ATTR-CM). A researcher studying genetic medicines under a microscope in a biopharmaceutical laboratory. As a result, AMVUTTRA is the first and only RNAi treatment approved in the EU for transthyretin amyloidosis symptoms that show as cardiomyopathy and polyneuropathy. The HELIOS-B Phase 3 research, which revealed a 36% mortality reduction over 42 months and a 28% decrease in all-cause mortality and recurrent cardiovascular events, served as the basis for the approval. More than 6,000 patient-years of safety data support the quarterly administration of the medication. The drug is already authorized in Brazil and the United States. Up to 100,000 individuals in Europe have ATTR amyloidosis, mostly as cardiomyopathy. An RNAi treatment called vutrisiran provides continuous knockdown by stopping TTR production at its source with quarterly injections. Functional and quality-of-life gains were validated by the HELIOS-B trial, which involved patients on SGLT2 inhibitors and tafamidis. Elevations of liver enzymes and injection site responses are frequent adverse effects. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is an innovator in the investigation of RNA interference medicines. While we acknowledge the potential of ALNY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
June is Men's Mental Health Awareness Month
AUGUSTA, Ga. (WJBF) – June is Men's Mental Health Awareness Month. I spoke to people who have seen boys and men silently struggle. When people think of depression, they typically think of sadness, specific language, or isolation, but in boys and men, it could look different. 'They may be more irritated. They may show a lot of aggression, a lot of anger, and so forth,' said Dominique Bond, School Counselor. 'So, these are some things that we can look for as well to really that can be some warning signs.' Marci Tankersley lost her brother to suicide. She tells me she never saw signs of him struggling with his mental health. 'The suicide rate in men is way higher than women, and I think that's why because they were never taught to express their emotions,' said Marci Tankersley, Mental Health Advocate. 'So that's the way my brother was raised. That's the way I mean so many men were raised, and my brother committed suicide when he was 21 years old. So, I don't remember him talking about anything. I didn't think he was depressed. But I do know now that he was, and he was silently struggling.' Mental health experts say the stigma that men can't show emotion makes it hard for them to express their feelings. 'Men need to really challenge their understanding of masculinity, and one of our understands of masculinity, which is very outdated, is that we are strong. We got it ourselves; we just got to tough it out, but in reality, we just have to address it,' said Bond. The American Foundation for Suicide Prevention aims to raise awareness through its 'Out of the Darkness' Walk in October. If you are struggling with mental health, you can also call the Suicide Hotline at 9-8-8. 'That tragedy and loss affects so many people down the line, The parents, the siblings. I just it can be, we can turn this thing around,' said Tankersley. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
